Primary-source record

MaterialTrial registry change

rintatolimod · NCT05927142 registry update

status: RECRUITING → ACTIVE_NOT_RECRUITING; primary_completion: 2026-04 → 2026-12

Key facts

Filed: Sep 29, 2026, 03:21 PM
Event: Trial registry change
Direction: Neutral
Company: AIMAIM ImmunoTech Inc.
Asset: rintatolimod
Source: ClinicalTrials.gov
Confidence: Sourced

More on this asset

May 14, 2026

12:45 PM

AIMAIM ImmunoTech Inc.

AIM ImmunoTech posts KOL segment on Ampligen pancreatic-cancer data

Conference presentationSEC 8-K

rintatolimod · NCT05927142 registry update | SimianX AI